Value proposition
At Eisai, human health care (hhc) is our goal.
Eisai’s Corporate Concept is “to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides.” Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.
In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), with working on various activities together with global partners.
Eisai Co., Ltd.｜A human health care company
Eisai Co., Ltd.｜A human health care company
https://www.eisai.com - Website is disabled or domain is for sale
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Positrigo Medical Equipment Manufacturing, healthtech, biotech, deeptech | Other 30 Oct 2024 | | |
 | CF Business Consulting and Services, healthtech | Other 18 May 2024 | | |
 | Medicines for Malaria Venture Non-profit Organizations, biotech, deeptech | Other 14 Dec 2023 | | |
 | Global Health Innovative Technology (GHIT) Fund Non-profit Organizations, healthtech, deeptech | Other 3 Feb 2025 | | |
 | European Pharmaceutical Manufacturer Book and Periodical Publishing | Other 15 Jan 2024 | | |
 | Edinburgh Innovations Research Services, deeptech | Other 3 Apr 2024 | | |
 | O-Kidia kidtech, Research Services, healthtech | Other 17 May 2023 | | |
 | Digital Health Blogs Broadcast Media Production and Distribution | Other 5 Feb 2024 | | |
 | UP for Humanness Non-profit Organizations, civictech | Other 22 May 2023 | | |
 | Neurotrack Biotechnology Research, biotech, deeptech | Other 28 Oct 2023 | | |
軽度認知症障害(MCI)と運転免許証
「免許返納」が話題になることがありますが、MCIと診断された場合は免許の更新はどうなるかご存じですか?
MCIと診断された場合、免許証の更新は認められますが、半年後に再検査にて症状が進んでないかの確認を行う必要があります。医師や専門家の助言を受けながら、安全を最優先にして運転を続けるべきかどうかを慎重に検討しましょう。テヲトルでは、運転に不安を感じた方へのチェックリストやご家族のサポートについて紹介しています☛軽度認知障害(MCI)と診断されたときの運転免許はどうなる?運転時認知障害早期発見チェックリストも紹介 (soudan-e65.com)
認知症ポータルサイト”テヲトル”(旧"相談e-65")は、エーザイグループのTheoria technologies(株)が運営しています。
#金曜日 #ブレインヘルス
先日、 2024年度「知の交流会」(社内研究発表会)が開催されました。
本年度は“Exciting Challenges Create the Future”をスローガンとして掲げ、本社や各研究所の社員が筑波研究所で一同に会しました。CEO内藤晴夫とCGO(チーフグロースオフィサー)内藤景介も参加し、創薬への情熱を胸に日々奮闘している筑波研究所の研究者たちの研究成果を確認しました。
「最新の科学技術を用いて新しい知見を得て創薬に熱く意欲的に挑戦することで、患者様と生活者様の未来を作っていく」という強い想いを共有し、互いに議論を深め、研究活動や未来の希望へのブースター、ひいては創薬の加速につながる機会となりました。
エーザイは、患者様とすべての生活者の皆様のために、創薬をさらに推進してまいります。
Recently, we held the “Knowledge Exchange Meeting FY2024 (internal R&D conference)” with the theme of “Exciting Challenges Create the Future”. Our employees from Eisai Headquarters and research laboratories gathered at Tsukuba Research Laboratories for the event.
CEO Haruo Naito and Chief Growth Officer (CGO) Keisuke Naito also joined the event to learn about research results presented by the dedicated scientists from Tsukuba Research Laboratories who work every day with great passion for drug discovery.
Sharing a strong desire to “create a future for patients and people in the daily living domain by passionately challenging drug discovery through new insights with cutting-edge scientific technologies”, scientists had deep discussions about research activities, hope for the future, and drug discovery acceleration.
Eisai is committed to further advancing drug discovery for patients and the people.
Eisai has been selected by the Ministry of Economy, Trade and Industry (#METI) and the Tokyo Stock Exchange (#TSE) as a #Nadeshiko Brand 2025 as a listed company excelling in the promotion of women in the workplace🎉 This marks our second consecutive inclusion on the list.
https://lnkd.in/gNDqdRFh
HAPPY WOMAN FESTA 2025 was held on March 8th International Women's Day, hosted by the HAPPY WOMAN Executive Committee and sponsored by Eisai's #ChocolaBB brand🌹
HAPPY WOMAN FESTA awards individuals and companies who have taken on challenges and engaged in activities that have contributed to women's empowerment and the promotion of SDGs. This year, Eriko Naito, President of Eisai’s Consumer hhc Business Division, served as the presenter at the awards ceremony.
The Chocola BB brand will continue to contribute to creating a society where all people can live happily and be themselves!